| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Biomarkers and surrogate markers: An FDA perspective
|
Katz, Russell
|
|
2004
|
1 |
2 |
p. 189-195
|
article
|
| 2 |
Biomarkers and Surrogate Markers: An FDA Perspective
|
Katz, Russell
|
|
2004
|
1 |
2 |
p. 189-195
7 p.
|
article
|
| 3 |
Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis
|
Miller, David H.
|
|
2004
|
1 |
2 |
p. 284-294
|
article
|
| 4 |
Biomarkers and Surrogate Outcomes in Neurodegenerative Disease: Lessons from Multiple Sclerosis
|
Miller, David H.
|
|
2004
|
1 |
2 |
p. 284-294
11 p.
|
article
|
| 5 |
Biomarkers and surrogates
|
Fox, Nick
|
|
2004
|
1 |
2 |
p. 181
|
article
|
| 6 |
Biomarkers and Surrogates
|
Fox, Nick
|
|
2004
|
1 |
2 |
p. 181-
1 p.
|
article
|
| 7 |
Biomarkers of Alzheimer disease in plasma
|
Irizarry, Michael C.
|
|
2004
|
1 |
2 |
p. 226-234
|
article
|
| 8 |
Biomarkers of Alzheimer Disease in Plasma
|
Irizarry, Michael C.
|
|
2004
|
1 |
2 |
p. 226-234
9 p.
|
article
|
| 9 |
Biomarkers: Potential uses and limitations
|
Mayeux, Richard
|
|
2004
|
1 |
2 |
p. 182-188
|
article
|
| 10 |
Biomarkers: Potential Uses and Limitations
|
Mayeux, Richard
|
|
2004
|
1 |
2 |
p. 182-188
7 p.
|
article
|
| 11 |
Cerebrospinal fluid protein biomarkers for Alzheimer’s disease
|
Blennow, Kaj
|
|
2004
|
1 |
2 |
p. 213-225
|
article
|
| 12 |
Cerebrospinal Fluid Protein Biomarkers for Alzheimer's Disease
|
Blennow, Kaj
|
|
2004
|
1 |
2 |
p. 213-225
13 p.
|
article
|
| 13 |
Genetics of Parkinson disease
|
Pankratz, Nathan
|
|
2004
|
1 |
2 |
p. 235-242
|
article
|
| 14 |
Genetics of Parkinson Disease
|
Pankratz, Nathan
|
|
2004
|
1 |
2 |
p. 235-242
8 p.
|
article
|
| 15 |
Huntington’s disease genetics
|
Myers, Richard H.
|
|
2004
|
1 |
2 |
p. 255-262
|
article
|
| 16 |
Huntington's Disease Genetics
|
Myers, Richard H.
|
|
2004
|
1 |
2 |
p. 255-262
8 p.
|
article
|
| 17 |
Measures and markers in Amyotrophic Lateral Sclerosis
|
Cudkowicz, Merit
|
|
2004
|
1 |
2 |
p. 273-283
|
article
|
| 18 |
Measures and Markers in Amyotrophic Lateral Sclerosis
|
Cudkowicz, Merit
|
|
2004
|
1 |
2 |
p. 273-283
11 p.
|
article
|
| 19 |
Molecular neuroimaging in Alzheimer’s disease
|
Jagust, William
|
|
2004
|
1 |
2 |
p. 206-212
|
article
|
| 20 |
Molecular Neuroimaging in Alzheimer's Disease
|
Jagust, William
|
|
2004
|
1 |
2 |
p. 206-212
7 p.
|
article
|
| 21 |
Neuroimaging in Parkinson’s disease
|
Brooks, David J.
|
|
2004
|
1 |
2 |
p. 243-254
|
article
|
| 22 |
Neuroimaging in Parkinson's Disease
|
Brooks, David J.
|
|
2004
|
1 |
2 |
p. 243-254
12 p.
|
article
|
| 23 |
Quantitative magnetic resonance techniques as surrogate markers of Alzheimer’s disease
|
Kantarci, Kejal
|
|
2004
|
1 |
2 |
p. 196-205
|
article
|
| 24 |
Quantitative Magnetic Resonance Techniques as Surrogate Markers of Alzheimer's Disease
|
Kantarci, Kejal
|
|
2004
|
1 |
2 |
p. 196-205
10 p.
|
article
|
| 25 |
Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington’s disease
|
Rosas, H. D.
|
|
2004
|
1 |
2 |
p. 263-272
|
article
|
| 26 |
Using Advances in Neuroimaging to Detect, Understand, and Monitor Disease Progression in Huntington's Disease
|
Rosas, H.D.
|
|
2004
|
1 |
2 |
p. 263-272
10 p.
|
article
|
Journal description